Insulin dependent diabetes mellitus in the non-obese diabetic mouse: a disease mediated by T cell anergy?

[1]  M. A. Bowman,et al.  Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. , 1994, Immunology today.

[2]  R. Tisch,et al.  Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice , 1993, Nature.

[3]  A. Tobin,et al.  Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes , 1993, Nature.

[4]  K. Pollok,et al.  Macrophage inflammatory protein-1 alpha rapidly modulates its receptors and inhibits the anti-CD3 mAb-mediated proliferation of T lymphocytes. , 1993, Journal of immunology.

[5]  T. Utsugi,et al.  Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice. , 1993, Journal of immunology.

[6]  K. Lafferty,et al.  The 12th International Immunology and Diabetes Workshop: Orlando, Florida , 1993, Diabetes.

[7]  J. Todd,et al.  Polygenic control of autoimmune diabetes in nonobese diabetic mice , 1993, Nature Genetics.

[8]  A Jaramillo,et al.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice , 1993, The Journal of experimental medicine.

[9]  K. Lafferty,et al.  Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. , 1993, Journal of autoimmunity.

[10]  A. Cooke,et al.  Prevention of diabetes but not insulitis in NOD mice injected with antibody to CD4. , 1993, Journal of autoimmunity.

[11]  A. Signore,et al.  NOD mouse colonies around the world--recent facts and figures. , 1993, Immunology today.

[12]  G. Eisenbarth,et al.  Insulin prophylaxis in individuals at high risk of type 1 diabetes , 1993, The Lancet.

[13]  R. Ransohoff,et al.  Astrocyte expression of mRNA encoding cytokines IP‐10 and JE/MCP‐1 in experimental autoimmune encephalomyelitis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  A. Jaramillo,et al.  Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation , 1993, The Journal of experimental medicine.

[15]  H. Gaskins,et al.  Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. , 1993, Journal of immunology.

[16]  F. Dagnaes-hansen,et al.  Prophylactic nutritional modification of the incidence of diabetes in autoimmune non-obese diabetic (NOD) mice , 1993, British Journal of Nutrition.

[17]  J. Satoh,et al.  Prevention of Autoimmune Diabetes with Lymphotoxin in NOD Mice , 1993, Diabetes.

[18]  E. Leiter.  The NOD Mouse: A Model for Analyzing the Interplay Between Heredity and Environment in Development of Autoimmune Disease , 1993 .

[19]  T. Saruta,et al.  Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. , 1992, Journal of autoimmunity.

[20]  O. Pankewycz,et al.  A protective NOD islet‐infiltrating CD8+ T cell clone, I.S. 2.15, has in vitro immunosuppressive properties , 1992, European journal of immunology.

[21]  T. Fahey,et al.  Macrophage inflammatory protein 1 modulates macrophage function. , 1992, Journal of immunology.

[22]  W. Paul,et al.  CD8+ T cells can be primed in vitro to produce IL-4. , 1992, Journal of immunology.

[23]  M. Charles,et al.  Quantitative and functional analyses of spleen and in situ islet immune cells before and after diabetes onset in the NOD mouse. , 1992, Autoimmunity.

[24]  Y. Fu,et al.  Linkage of faulty major histocompatibility complex class I to autoimmune diabetes. , 1991, Science.

[25]  M. McGill,et al.  Insulitis in type 1 (insulin‐dependent) diabetes mellitus in man—macrophages, lymphocytes, and interferon‐γ containing cells , 1991, The Journal of pathology.

[26]  D. Mason,et al.  Subsets of CD4+ T Cells and their Roles in the Induction and Prevention of Autoimmunity , 1991, Immunological reviews.

[27]  Roberta,et al.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.

[28]  Soumitra Ghosh,et al.  Genetic analysis of autoimmune type 1 diabetes mellitus in mice , 1991, Nature.

[29]  M. Hadzija,et al.  Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. , 1991, Journal of immunology.

[30]  W. Paul,et al.  IL-4 increases IL-2 production by T cells in response to accessory cell-independent stimuli. , 1991, Journal of immunology.

[31]  T. Schall.  Biology of the RANTES/SIS cytokine family. , 1991, Cytokine.

[32]  T. Delovitch,et al.  Altered Thymic and Peripheral T-Lymphocyte Repertoire Preceding Onset of Diabetes in NOD Mice , 1991, Diabetes.

[33]  P. Bedossa,et al.  Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. , 1991, Journal of autoimmunity.

[34]  E. Marliss,et al.  Conference summary: diet as an environmental factor in development of insulin-dependent diabetes mellitus. , 1991, Canadian journal of physiology and pharmacology.

[35]  K. Matsushima,et al.  Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.

[36]  D. Lacey,et al.  IL-1 and IL-4 modulate IL-1 receptor expression in a murine T cell line. , 1990, Journal of immunology.

[37]  S. Gordon,et al.  Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages , 1990, Nature.

[38]  S. Ihm,et al.  Studies on Autoimmunity for Initiation of β-Cell Destruction: VI. Macrophages Essential for Development of β-Cell–Specific Cytotoxic Effectors and Insulitis in NOD Mice , 1990, Diabetes.

[39]  M. Atkinson,et al.  Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy , 1990, Diabetes.

[40]  D. Kioussis,et al.  Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain , 1990, Nature.

[41]  L. Kjer-Nielsen,et al.  Prevention of diabetes in non-obese diabetic I-Ak transgenic mice , 1990, Nature.

[42]  J. Miyazaki,et al.  Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice , 1990, Nature.

[43]  B. Vialettes,et al.  Paradoxical lessening of autoimmune processes in non‐obese diabetic mice afterinfection with the diabetogenic variant of encephalomyocarditis virus , 1990, European journal of immunology.

[44]  M. Sadelain,et al.  Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy , 1990, Diabetes.

[45]  K. Lafferty,et al.  Ectopic class II MHC antigen expression and the development of diabetes. , 1990, Journal of autoimmunity.

[46]  A. Cooke,et al.  The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. , 1990, Journal of autoimmunity.

[47]  K. Hamaguchi,et al.  Viruses and diabetes: diabetogenic role for endogenous retroviruses in NOD mice? , 1990, Journal of autoimmunity.

[48]  P. D’Eustachio,et al.  Clustering of cytokine genes on mouse chromosome 11 , 1990, The Journal of experimental medicine.

[49]  T. Ichikawa,et al.  A single recessive non-MHC diabetogenic gene determines the development of insulitis in the presence of an MHC-linked diabetogenic gene in NOD mice. , 1990, Journal of autoimmunity.

[50]  A. Cerami,et al.  Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[51]  K. Hamaguchi,et al.  Immunostimulation circumvents diabetes in NOD/Lt mice. , 1989, Journal of autoimmunity.

[52]  R. Houghten,et al.  Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants. Influence of peptide-MHC interaction. , 1989, Journal of immunology.

[53]  G. Delespesse,et al.  Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells , 1989, The Journal of experimental medicine.

[54]  A. Baxter,et al.  Comparison of high and low diabetes incidence non-obese diabetic mouse strains , 1989 .

[55]  A. Baxter,et al.  Comparison of High— and Low—Diabetes-Incidence NOD Mouse Strains , 1989, Diabetes.

[56]  A. Hayward,et al.  Neonatal injection of CD3 antibody into nonobese diabetic mice reduces the incidence of insulitis and diabetes. , 1989, Journal of immunology.

[57]  E. Leiter.  The genetics of diabetes susceptibility in mice , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  V. Kuchroo,et al.  Functional analysis of cloned macrophage hybridomas. VII. Modulation of suppressor T cell-inducing activity. , 1989, Journal of immunology.

[59]  H. Rammensee,et al.  Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells , 1989, Nature.

[60]  C. Boitard,et al.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice , 1989, The Journal of experimental medicine.

[61]  J. West,et al.  A monoclonal antibody to murine CD45R distinguishes CD4 T cell populations that produce different cytokines , 1989, European journal of immunology.

[62]  H. Waldmann,et al.  Induction of classical transplantation tolerance in the adult , 1989, The Journal of experimental medicine.

[63]  P. Bedossa,et al.  Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. , 1988, Journal of immunology.

[64]  E. Leiter,et al.  Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies. , 1988, Journal of immunology.

[65]  J. Bach,et al.  Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod mice , 1988, European journal of immunology.

[66]  M. Oldstone.  Prevention of type I diabetes in nonobese diabetic mice by virus infection. , 1988, Science.

[67]  A. Rabinovitch,et al.  Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 , 1988, Diabetes.

[68]  L. Wicker,et al.  Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. , 1988, Journal of immunology.

[69]  P. in’t Veld,et al.  Islet morphologic changes. , 1987, Diabetes/metabolism reviews.

[70]  C. Boitard,et al.  Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells , 1987, The Journal of experimental medicine.

[71]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[72]  T. Hanafusa,et al.  Elevated antibody-dependent cell-mediated cytotoxicity and its inhibition by nicotinamide in the diabetic NOD mouse. , 1986, Immunology letters.

[73]  D. R. Gamble,et al.  In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.

[74]  Y. Tochino,et al.  The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice , 1985 .

[75]  R. Spielman,et al.  Decreased Synthesis of Interleukin-2 (IL-2) in Insulin-dependent Diabetes Mellitus , 1984, Diabetes.

[76]  T. Fujita,et al.  LYMPHOCYTIC INSULITIS IN A ‘NON-OBESE DIABETIC (NOD)’ STRAIN OF MICE: AN IMMUNOHISTOCHEMICAL AND ELECTRON MICROSCOPE INVESTIGATION , 1982 .

[77]  Y. Tochino,et al.  Breeding of a non-obese, diabetic strain of mice. , 1980, Jikken dobutsu. Experimental animals.

[78]  Å. Lernmark,et al.  Islet-cell-surface antibodies in juvenile diabetes mellitus. , 1978, The New England journal of medicine.